Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion type Assertion NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_head.
- NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion description "[Although several COX-2 inhibitors have been used in hepatoma therapy, the genetic background between COX-2 and HCC remains largely unknown.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_provenance.
- NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion evidence source_evidence_literature NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_provenance.
- NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion SIO_000772 22242948 NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_provenance.
- NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion wasDerivedFrom befree-2016 NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_provenance.
- NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_assertion wasGeneratedBy ECO_0000203 NP953063.RAhofhn2dRdbjaBcMkeWpOnFPMs8pJ99YZvpQ-IZPcQes130_provenance.